Cargando…
Challenges in Glioblastoma Radiomics and the Path to Clinical Implementation
SIMPLE SUMMARY: Glioblastoma (GBM) is a cancer with poor prognosis, its 5-year survival expectation is approximately 5%. Advances in oncologic treatment techniques have not led to significant improvements in survival outcomes for GBM patients. Part of the reason for the treatment failures in GBM pat...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406186/ https://www.ncbi.nlm.nih.gov/pubmed/36010891 http://dx.doi.org/10.3390/cancers14163897 |